It's Now Even Easier to Prescribe HCV Treatments
COVID-19 Vaccine FAQs - Hepatitis and Liver Disease
Australia’s supply of COVID-19 vaccines is now being rolled out in stages across the country.…Read Article
Help fight viral hepatitis: Call for stories
Five common liver cancer myths
In honour of World Cancer Day on the 4th of February, Hepatitis Queensland is busting…Read Article
Changes to the Pharmaceutical Benefits Scheme (PBS) from 1st April mean:
- virus genotype is no longer required before prescribing treatment, and
- the 18+ age restriction has also been removed.
Pangenotypic treatments, available under the PBS, are suitable for all hepatitis C genotypes. GPs can find more information about treating hepatitis C on our GP Resources page.